Although higher levels of anti-CDC25B antibodies were found in the sera of patients with ESCC than in the sera of healthy controls, the relationship between tumor burden, tumor staging and antibody levels remains unknown. This evidence concerns the gene CDC25B and esophageal squamous cell carcinoma.